COVID - 19和流感合并感染:迫在眉睫的“双重打击”?

IF 0.5 Q4 ENDOCRINOLOGY & METABOLISM Practical Diabetes Pub Date : 2022-11-01 DOI:10.1002/pdi.2421

K. Shaw

{"title":"COVID - 19和流感合并感染:迫在眉睫的“双重打击”?","authors":"K. Shaw","doi":"10.1002/pdi.2421","DOIUrl":null,"url":null,"abstract":"A the winter of 2022–23 approaches, concern is already developing about the prospect of a dual co-infection with simultaneous SARS-CoV-2 (COVID-19/ Omicron) and influenza A (currently H3N2). Furthermore, as a result of essential measures put in place over the last couple of years to mitigate risk of transmitting COVID infection, the incidence of seasonal influenza has been substantially less than in previous years, raising the potential probability of a more susceptible population with a lessened natural immunity to influenza infection. Indeed, present reports from Australia, inevitably the prelude to later western experience, indicate a rapid rise in influenza A notifications, a challenge reinforced by declining uptake of seasonal influenza vaccine both in Australia and the UK.1","PeriodicalId":20309,"journal":{"name":"Practical Diabetes","volume":"14 1","pages":"3 - 4"},"PeriodicalIF":0.5000,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Combined COVID‐19 and influenza infection: an imminent ‘double whammy’ ahead?\",\"authors\":\"K. Shaw\",\"doi\":\"10.1002/pdi.2421\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"A the winter of 2022–23 approaches, concern is already developing about the prospect of a dual co-infection with simultaneous SARS-CoV-2 (COVID-19/ Omicron) and influenza A (currently H3N2). Furthermore, as a result of essential measures put in place over the last couple of years to mitigate risk of transmitting COVID infection, the incidence of seasonal influenza has been substantially less than in previous years, raising the potential probability of a more susceptible population with a lessened natural immunity to influenza infection. Indeed, present reports from Australia, inevitably the prelude to later western experience, indicate a rapid rise in influenza A notifications, a challenge reinforced by declining uptake of seasonal influenza vaccine both in Australia and the UK.1\",\"PeriodicalId\":20309,\"journal\":{\"name\":\"Practical Diabetes\",\"volume\":\"14 1\",\"pages\":\"3 - 4\"},\"PeriodicalIF\":0.5000,\"publicationDate\":\"2022-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Practical Diabetes\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1002/pdi.2421\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Practical Diabetes","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/pdi.2421","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}

引用次数: 0

摘要

随着2022-23年冬季的临近，人们已经开始担心SARS-CoV-2 (COVID-19/ Omicron)和甲型流感(目前为H3N2)双重合并感染的前景。此外，由于过去几年为降低传播COVID感染的风险而采取的基本措施，季节性流感的发病率已大大低于往年，从而增加了对流感感染的天然免疫力降低的易感人群的潜在可能性。事实上，目前来自澳大利亚的报告，不可避免地是后来西方经验的前奏，表明甲型流感报告迅速增加，澳大利亚和英国季节性流感疫苗的接种率下降加强了这一挑战

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Combined COVID‐19 and influenza infection: an imminent ‘double whammy’ ahead?

A the winter of 2022–23 approaches, concern is already developing about the prospect of a dual co-infection with simultaneous SARS-CoV-2 (COVID-19/ Omicron) and influenza A (currently H3N2). Furthermore, as a result of essential measures put in place over the last couple of years to mitigate risk of transmitting COVID infection, the incidence of seasonal influenza has been substantially less than in previous years, raising the potential probability of a more susceptible population with a lessened natural immunity to influenza infection. Indeed, present reports from Australia, inevitably the prelude to later western experience, indicate a rapid rise in influenza A notifications, a challenge reinforced by declining uptake of seasonal influenza vaccine both in Australia and the UK.1

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Practical Diabetes ENDOCRINOLOGY & METABOLISM-

CiteScore

1.10

自引率

16.70%

发文量

期刊介绍： Practical Diabetes concerns itself with all aspects of the worldwide clinical science and practice of diabetes medicine. The journal recognises the importance of each member of the healthcare team in the delivery of diabetes care, and reflects this diversity of professional interest in its editorial contents. The Editors welcome original papers, case reports, practice points, audit articles and letters on any aspect of clinical diabetes care from any part of the world. The journal also publishes commissioned leaders, review articles and educational and training series, for which an honorarium normally is paid. All articles submitted to Practical Diabetes are independently peer reviewed. They must not have been published or be under submission currently elsewhere. Enquiries from prospective authors are welcomed and the Editors will be pleased, if asked, to advise on preparation and submission of articles. All articles and enquiries should be directed to the Editors at the publishing address below. The journal is published nine times a year, and currently the average waiting time for acceptance of articles is eight weeks, and for subsequent publication sixteen weeks. Practical Diabetes is independent of any commercial or vested interest.